# Detrol Long Acting (LA) vs Estrace Vaginal Cream for the Treatment of Overactive Bladder Symptoms

> **NCT00465894** · NA · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 58 (actual)

## Conditions studied

- Overactive Bladder

## Interventions

- **DRUG:** Extended Release Tolterodine LA
- **DRUG:** Intra Vaginal Estradiol Cream

## Key facts

- **NCT ID:** NCT00465894
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2010-07
- **Final completion:** 2011-12
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2018-11-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00465894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00465894, "Detrol Long Acting (LA) vs Estrace Vaginal Cream for the Treatment of Overactive Bladder Symptoms". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00465894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*